keyword
https://read.qxmd.com/read/38338288/integrative-medicine-for-cancer-related-pain-a-narrative-review
#21
REVIEW
Noah Samuels, Eran Ben-Arye
Cancer-related pain (C-RP) is a prevalent and debilitating concern among patients with cancer, with conventional treatments limited in their ability to provide adequate relief, and by the adverse effects associated with their use. Complementary and integrative medicine (CIM) modalities have been shown to be potentially effective and safe for the treatment of pain and related symptoms, when used in conjunction with conventional medications and under medical supervision. An increasing number of oncology centers provide CIM within their conventional supportive and palliative care service, in an "Integrative Oncology" (IO) setting...
February 4, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38335396/treatment-of-lung-cancer-by-acupuncture-combined-with-medicine-based-on-pathophysiological-mechanism-a-review
#22
JOURNAL ARTICLE
Chenguang Guan, Hong Chen, Haipeng Chen, Shuhua Li, Yuhan Chen, Jingyu Chen, Yushan Dong, Zhitao Zheng, Kaiwen Wang, Chuqiao Pan
Lung cancer is one of the most frequently diagnosed cancers in the world. There are an estimated 2.2 million new cases and 1.79 million deaths each year. Over the past 2 decades, our understanding of disease biology, the use of predictive biomarkers, and improvements in therapeutic approaches have made significant progress and transformed the outcomes of many patients. Treatment is determined by the subtype and stage of the cancer; however, the effect of personalized treatment remains unsatisfactory. The use of Chinese medicines has attracted increasing attention worldwide...
February 9, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38329790/role-of-chinese-acupuncture-in-the-treatment-for-chemotherapy-induced-cognitive-impairment-in-older-patients-with-cancer-protocol-for-a-randomized-controlled-trial
#23
JOURNAL ARTICLE
Sunyan Zhao, Jing Zhang, Haijun Wan, Chenjie Tao, Meng Hu, Wei Liang, Zhi Xu, Bingguo Xu, Jiaying Zhang, Guoxin Wang, Ping Li, Guangmei Lyu, Yongling Gong
BACKGROUND: Older patients with cancer experience cognitive impairment and a series of neurocognitive symptoms known as chemobrain due to chemotherapy. Moreover, older populations are disproportionately affected by chemobrain and heightened negative mental health outcomes after cytotoxic chemical drug therapy. Chinese acupuncture is an emerging therapeutic option for chemotherapy-induced cognitive impairment in older patients with cancer, despite limited supporting evidence. OBJECTIVE: Our study aims to directly contribute to the existing knowledge of this novel Chinese medicine mode in older patients with cancer enrolled at the Department of Oncology/Chinese Medicine, Nanjing First Hospital, China, thereby establishing the basis for further research...
February 8, 2024: JMIR Research Protocols
https://read.qxmd.com/read/38328830/the-effectiveness-of-traditional-chinese-medicine-in-treating-malignancies-via-regulatory-cell-death-pathways-and-the-tumor-immune-microenvironment-a-review-of-recent-advances
#24
JOURNAL ARTICLE
Jingya Fu, Xiaoxia Xie, Huimin Yao, Haijuan Xiao, Zhuoqun Li, Zhenzhi Wang, Ran Ju, Yan Zhao, Zhijun Liu, Nana Zhang
Traditional Chinese Medicine (TCM) has achieved high clinical efficacy in treating malignancies in recent years and is thus gradually becoming an important therapy for patients with advanced tumor for its benefits in reducing side effects and improving patients' immune status. However, it has not been internationally recognized for cancer treatment because TCM's anti-tumor mechanism is not fully elucidated, limiting its clinical application and international promotion. This review traced the mechanism of the TCM-mediated tumor cell death pathway and its effect on remodeling the tumor immune microenvironment, its direct impact on the microenvironment, its anti-tumor effect in combination with immunotherapy, and the current status of clinical application of TCM on tumor treatment...
February 7, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38328829/ferroptosis-a-new-research-direction-of-artemisinin-and-its-derivatives-in-anti-cancer-treatment
#25
JOURNAL ARTICLE
Youke Wang, Xiang Yuan, Min Ren, Zhiyu Wang
Ferroptosis, an iron-dependent cell death mechanism driven by an accumulation of lipid peroxides on cellular membranes, has emerged as a promising strategy to treat various diseases, including cancer. Ferroptosis inducers not only exhibit cytotoxic effects on multiple cancer cells, including drug-resistant cancer variants, but also hold potential as adjuncts to enhance the efficacy of other anti-cancer therapies, such as immunotherapy. In addition to synthetic inducers, natural compounds, such as artemisinin, can be considered ferroptosis inducers...
February 7, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38316611/a-randomized-controlled-study-on-acupuncture-for-peri-operative-pain-after-open-radical-prostatectomy
#26
JOURNAL ARTICLE
Jean Maurer, Thomas Friedemann, Yuelai Chen, Francesca Ambrosini, Sophie Knipper, Tobias Maurer, Hans Heinzer, Imke Thederan, Sven Schroeder
OBJECTIVES: To evaluate the advantages of adding acupuncture to standard postoperative pain management for open radical prostatectomy (RP). MATERIALS AND METHODS: A randomized controlled trial (1:1:1) comparing routine postoperative analgesic care (control [CON]) vs the addition of press tack needle acupuncture (ACU) or press tack placebo acupressure (SHAM) for pain management after open RP was performed. A total of 126 patients were enrolled between February 2020 and April 2021...
February 5, 2024: BJU International
https://read.qxmd.com/read/38298287/adverse-events-of-the-long-term-use-of-opioids-for-chronic-non-cancer-pain-a-narrative-review
#27
REVIEW
Abdullh A Altawili, Mohammed A Altawili, Amnah H Alzarar, Noor M Abdulrahim, Haidar H Alquraish, Maryam A Alahmari, Marouj H Basyouni, Yara A Almohaya, Wafa Mohammed S Alhabshan, Abdullah Mohammed A Alshahrani, Jafar Faraj A Alamrad, Ahmad S Aljumaah, Mohammed A Alsalman, Abdullah A Alhafith
BACKGROUND: The long-term use of opioids for chronic non-cancer pain (CNCP) has drawn more attention and debate. Although opioids are frequently used to treat chronic pain, their effectiveness and safety over extended periods are still unknown. OBJECTIVES: The purpose of this review is to provide an overview of what is currently known about the adverse events of long-term use of opioids in CNCP. It also delivers patient-centered strategies designed to mitigate these risks...
January 2024: Curēus
https://read.qxmd.com/read/38294598/the-development-and-flux-of-the-university-of-minnesota-survivorship-program-progress-challenges-and-opportunities
#28
REVIEW
Tara J Rick, Jill Lee, Sasha Skendzel, Kaia Verich, Ashley Schempp, Char Napurski, Holly Kreuser, Lucie Turcotte, Shernan Holtan, Karim Sadak, Anne Blaes
For the past 30 years, the University of Minnesota's Cancer Survivorship Program has been dedicated to providing exceptional care to patients who have lived the cancer experience. Our model is consultative, risk-stratified, and oncologist-led but executed predominately by advanced practice providers. Care is personalized and serves three survivor populations: children, adults, and patients who received BMT with over 500 new patients evaluated annually. As guidelines and survivorship standards have changed, our clinical programs have evolved from a focus on survivorship care plans to supportive care...
January 31, 2024: Journal of Cancer Survivorship: Research and Practice
https://read.qxmd.com/read/38293347/research-trends-and-frontier-hotspots-of-trpv1-based-on-bibliometric-and-visualization-analyses
#29
REVIEW
Jingchun Zeng, Yiqian Lu, Hui Chu, Liming Lu, Yuexuan Chen, Kaisong Ji, Yeze Lin, Jingjing Li, Shuxin Wang
BACKGROUND: Transient receptor potential vanilloid type1 (TRPV1) is a non-selective cation channel with multiple activation mechanisms, which has received increasing attention since it was first cloned in 1997. METHODS: We used bibliometric and visualization analyses to evaluate the theme trends and knowledge structure of TRPV1 research-papers on TRPV1 from 2002 to 2022 obtained from the Web of Science Core Collection. VOSviewer and CiteSpace were used to analyze authors, institutions, countries, co-cited references, and keywords...
January 30, 2024: Heliyon
https://read.qxmd.com/read/38291957/are-published-cancer-care-trial-protocols-with-traditional-chinese-medicine-interventions-concordant-with-spirit-tcm-extension-2018-a-scoping-review-on-published-trial-protocols-between-2019-and-2022
#30
REVIEW
Hezheng Lai, Peiying Yang, Xin Shelley Wang, David Lim, Anderson Lam, Yucong Shi, Yishi Huang, Xiaoshu Zhu
BACKGROUND: The SPIRIT-TCM Extension 2018 was created to guide the design and reporting of Traditional Chinese Medicine (TCM) clinical trial protocols. This study aims to investigate the extent of concordance with this guideline in the relevant field of cancer care research. METHODS: A scoping review of TCM cancer trial protocols published in English and Chinese since January 2019 was conducted. Five major academic databases (MEDLINE, EMBASE, CINAHL, CENTRAL, and China National Knowledge Infrastructure) were searched...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/38291583/cucurbitacin-b-inhibits-the-malignancy-of-esophageal-carcinoma-through-the-kif20a-jak-stat3-signaling-pathway
#31
JOURNAL ARTICLE
Chao Liu, Jian Ji, Chenglin Li
This study intends to explore the effects of Cucurbitacin B (CuB) and KIF20A on esophageal carcinoma (ESCA). Data were downloaded from the Cancer Genome Atlas (TCGA) database. The expression properties of KIF20A have been confirmed by GEPIA and ualcan from TCGA. The expression of KIF20A was determined using western blotting in ECA109 and KYSE150 cells after transfection with KIF20A, KIF20A siRNA, or numerical control siRNA (si-NC). Then, different concentrations of CuB were used to treat ECA109 and KYSE150 cells...
January 30, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38291582/research-progress-on-the-antitumor-molecular-mechanism-of-ginsenoside-rh2
#32
JOURNAL ARTICLE
Lan Yang, Jenny Jie Chen, Brian Sheng-Xian Teo, Jiong Zhang, Mingqiang Jiang
Cancer has evolved into a substantial public health concern as the second-leading cause of mortality globally. Radiotherapy and chemotherapy have been the two most widely used cancer therapies in recent years; however, both have drawbacks. Therefore, the focus has shifted to the creation of herbal medicines, the extraction of active ingredients, replacement therapy, and the adverse effects of these medications. Ginsenoside Rh2, which is extracted from ginseng, has been identified in many cancer cells. The immune system of the body is strengthened by ginsenoside Rh2, which can also cause the proliferation, death, and differentiation of tumor cells through various pathways...
January 31, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38288552/characteristics-and-challenges-of-providing-acupuncture-and-chinese-herbal-medicine-in-oncology-treatment-report-of-survey-data-and-experience-of-five-unique-clinical-settings
#33
JOURNAL ARTICLE
Susan Veleber, Misha Ruth Cohen, Matthew Weitzman, Yair Maimon, Christine A Adamo, Jonathan Siman, Weidong Lu, Tammy Sajdyk, Jennifer A M Stone
Acupuncture is an integrative therapy with strong evidence to support its use in the oncology setting, yet barriers exist for implementation into conventional medical clinics. Though acupuncture is recommended in clinical practice guidelines for oncology, there is little data in the literature showing how acupuncture and other related therapies, including herbal medicine are successfully implemented in some oncology clinics, while others experience barriers to care. To characterize the current use of acupuncture (ACU) and herbal medicine (HM) in oncology clinics, we collected general demographic and usage data from 5 example clinics...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/38281918/cancer-pain-management-with-traditional-chinese-medicine-current-status-and-future-perspectives
#34
JOURNAL ARTICLE
Jiafu Ji, Jingxuan Guo, Yongliang Chi, Fan Su
Cancer pain, especially the moderate-to-severe pain experienced by patients with advanced cancer, is still one of the most challenging clinical problems. The current mainstream pharmacological treatment for cancer pain involves applying opioid medications and other pain-killing drugs. However, analgesic drugs have many adverse effects such as addiction, tolerance, and other formidable clinical and social issues. Thus, finding a new therapeutic approach to treat cancer pain is essential. Traditional Chinese medicine (TCM) has been increasingly applied in clinical practice because of its good efficacy and few side effects...
January 26, 2024: American Journal of Chinese Medicine
https://read.qxmd.com/read/38255105/development-and-validation-of-an-auricular-acupuncture-protocol-for-the-management-of-chemotherapy-induced-nausea-and-vomiting-in-cancer-patients
#35
JOURNAL ARTICLE
Eliza Mara das Chagas Paiva, Caroline de Castro Moura, Denismar Alves Nogueira, Ana Cláudia Mesquita Garcia
Auricular acupuncture (AA) has been used to manage chemotherapy-induced nausea and vomiting (CINV). However, the application of the technique varies widely among the clinical trials that test its effectiveness. The aim of the present study was to develop and clinically validate an AA protocol for the management of CINV in cancer patients. This study was carried out in two stages: (1) development of the AA protocol for the management of CINV and (2) clinical validation of the protocol. The content validity of the protocol was determined by a panel of specialists, with an agreement rate ranging from 85...
January 16, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38243739/implementation-of-virtual-integrative-oncology-shared-medical-appointment-series-viosmas-within-mixed-diagnosis-population
#36
JOURNAL ARTICLE
Michelle H Loy, Lauren Prisco, Chiti Parikh
BACKGROUND: Integrative oncology [IO] is sought-after by patients, endorsed by clinical guidelines, and valued within National Cancer Institute Centers. Shared Medical Appointments [SMA] leverage health education and social connection to deliver enhanced patient experience, population health, cost-reduction, and clinician well-being. Integrative Oncology Shared Medical Appointments increase access to integrative medicine but delivering these services via telehealth have not been evaluated...
2024: Integrative Cancer Therapies
https://read.qxmd.com/read/38215092/stellate-ganglion-block-with-procaine-in-breast-cancer-survivors-with-hot-flashes-and-sleep-disturbances-undergoing-endocrine-therapy
#37
JOURNAL ARTICLE
Sven Soecknick
Breast cancer survivors under endocrine therapy (ET) suffer from side effects such as hot flashes and sleep disturbance accompanied by poor quality of life. Many quit ET early and reduce their survival rate. Guidelines recommend gabapentin next to yoga or acupuncture. The role of side effects related to compliance with ET over years require new and effective therapies. Stellate ganglion block (SGB) has shown evidence of safety and efficacy and was found to be more effective than pregabalin without side effects...
January 12, 2024: Medicine (Baltimore)
https://read.qxmd.com/read/38201526/antitumoral-agent-induced-constipation-a-systematic-review
#38
REVIEW
Agnès Calsina-Berna, Jesús González-Barboteo, Silvia Llorens-Torromé, Joaquim Julià-Torras
BACKGROUND: Constipation is a common symptom in patients receiving antitumoral treatment. The mechanisms underlying antitumoral agent-induced constipation (ATAIC) are poorly defined. This systematic review aimed to analyze and synthesize the available information related to the prevalence, etiology, and treatment of ATAIC. METHODS: A systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analysis (PRISMA) guidelines was conducted...
December 24, 2023: Cancers
https://read.qxmd.com/read/38199884/mapping-the-clinical-practice-of-traditional-complementary-and-integrative-medicine-in-oncology-in-western-countries-a-multinational-cross-sectional-survey
#39
JOURNAL ARTICLE
Matthias Huemer, Sandro Graca, Sarah Bitsche, Guenter Hofmann, Mike Armour, Martin Pichler
BACKGROUND: Many cancer patients seek adjunctive therapies to biomedical cancer treatments at some point of their disease trajectory. While acupuncture is increasingly recommended by leading oncological associations, limited evidence exists concerning the evidence-informed practice and adherence to current guidelines of traditional complementary and integrative medicine (TCIM) practitioners treating cancer patients. METHODS: An international online-survey assessed the demographical data, clinical practice, and sources of information used by TCIM practitioners in Austria, Germany, United States of America, Australia, and New Zealand...
December 28, 2023: Journal of Integrative Medicine
https://read.qxmd.com/read/38195173/electroacupuncture-use-for-treatment-of-taxane-induced-peripheral-neuropathy-in-patients-with-breast-cancer-protocol-for-a-pilot-randomised-blinded-sham-controlled-trial-ea-for-cipn
#40
JOURNAL ARTICLE
Victoria Choi, Susanna B Park, Judith Lacey, Sanjeev Kumar, Gillian Heller, Peter Grimison
INTRODUCTION: Chemotherapy-induced peripheral neuropathy (CIPN) is a common dose-limiting side effect of neurotoxic chemotherapy. Acute symptoms of CIPN during treatment can lead to dose reduction and cessation. Trials using electroacupuncture (EA) to treat established CIPN postchemotherapy have shown some efficacy. The current trial aims to assess the feasibility and preliminary efficacy of using EA to treat CIPN during chemotherapy. METHODS AND ANALYSIS: The current study is a single-centre, 1:1 randomised, sham-controlled pilot study set in a tertiary cancer hospital in Sydney, Australia, and will recruit 40 adult patients with early breast cancer undergoing adjuvant or neoadjuvant paclitaxel chemotherapy...
January 9, 2024: BMJ Open
keyword
keyword
2490
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.